New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

3

ImmunoGen and Gilead team up to target AML

ImmunoGen entered into a clinical collaboration deal with Gilead Sciences Friday to evaluate the safety and efficacy of two drugs that, when used in concert, have the potential to treat AML, a blood disorder biopharma has found challenging to target. 

10

Social determinants of health: Making an impact

One of the advantages of leveraging behavioral science in healthcare marketing is that it provides marketers with powerful tools to do what we do best: solve problems. Once we are able to identify the unique behavioral barriers at play, the science leads us toward solutions that are likely to be successful in addressing them. But what happens when we are faced with behavioral challenges that are not so clearly solvable?